We always have the patients in our mind. This is the drive that motivates us to do what we do. Well done Gilli Bader
Isotopia Molecular Imaging ltd generously donated the first doses of Lu-177 to a patient who could not get access to the treatment. The success of this initiative inspired us to develop #RLTConnect, a platform that connects healthcare professionals with radioisotope suppliers to provide #RadioligandTherapy for #CancerCare where this treatment is not yet reimbursed. “We always have the patients in our mind. This is the drive that motivates us to do what we do,” shared Gilli Bader, Global Sales Director, Therapy at Isotopia, when asked about their motivation to join this Oncidium Foundation initiative. Their commitment and efforts to overcome access barriers in terms of logistics and availability serve as an example to encourage more collaboration to enhance global access to RLT. Do you want to be part of this journey? Register today! https://buff.ly/3wSlTuJ
Keep the good work gili
Inspiring!
Great work
Chef d'entreprise
1moHi Oncidium team....dont forget that, as discussed in Toronto, our company ISI is still ready to contribute to this fantastic project offering the transportation....best regards Claude